Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies.

The ubiquitin-proteasome system is a master regulator of protein homeostasis, by which proteins are initially targeted for poly-ubiquitination by E3 ligases and then degraded into short peptides by the proteasome. Nature evolved diverse peptidic motifs, termed degrons, to signal substrates for degradation. We discuss degrons of the N-end rule pathway and also degrons characterized by post-translational modifications, including phosphorylation and hydroxylation. In each case we detail the structural basis of E3 ligase:degron recognition and small-molecule mimicry approaches that disrupt those protein-protein interactions. We present as well genetic and chemical technologies that enable targeted degradation of proteins of interest, namely small-molecule dependent inducible degrons and chemical degraders, for example, proteolysis-targeting chimeras (PROTACs).

[1]  A. Ciulli,et al.  Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation , 2015, The Biochemical journal.

[2]  Christopher J. Ott,et al.  The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins , 2014, Science.

[3]  Yong Tae Kwon,et al.  Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.

[4]  A. Varshavsky.  Naming a targeting signal , 1991, Cell.

[5]  H. Handa,et al.  Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs , 2014, Nature Structural &Molecular Biology.

[6]  J Wade Harper,et al.  Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. , 2007, Molecular cell.

[7]  Yong Tae Kwon,et al.  The N-end rule pathway: emerging functions and molecular principles of substrate recognition , 2011, Nature Reviews Molecular Cell Biology.

[8]  Joonhee Kim,et al.  Structural basis for the recognition of N-end rule substrates by the UBR box of ubiquitin ligases , 2010, Nature Structural &Molecular Biology.

[9]  Raymond J. Deshaies,et al.  Function and regulation of cullin–RING ubiquitin ligases , 2005, Nature Reviews Molecular Cell Biology.

[10]  David Balchin,et al.  In vivo aspects of protein folding and quality control , 2016, Science.

[11]  L. Hennighausen,et al.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. , 2008, Genes & development.

[12]  C. Schofield,et al.  Targeting Protein–Protein Interactions in the HIF System , 2016, ChemMedChem.

[13]  P. Tompa,et al.  Tripartite degrons confer diversity and specificity on regulated protein degradation in the ubiquitin-proteasome system , 2016, Nature Communications.

[14]  Geng Wu,et al.  Structure of a -TrCP1-Skp1--Catenin Complex , 2003 .

[15]  Nadine H. Elowe,et al.  An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase , 2010, Nature Biotechnology.

[16]  David I Stuart,et al.  Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. , 2002, Nature.

[17]  M. Tyers,et al.  Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCFCdc4 Ubiquitin Ligase , 2003, Cell.

[18]  Y. Saga,et al.  Rapid Protein Depletion in Human Cells by Auxin-Inducible Degron Tagging with Short Homology Donors. , 2016, Cell reports.

[19]  Michal Sharon,et al.  Mechanism of auxin perception by the TIR1 ubiquitin ligase , 2007, Nature.

[20]  Jeremy L. Jenkins,et al.  Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide , 2014, Nature.

[21]  Yong Tae Kwon,et al.  The N-end rule pathway. , 2012, Annual review of biochemistry.

[22]  Kay Hofmann,et al.  Selective autophagy: ubiquitin-mediated recognition and beyond , 2010, Nature Cell Biology.

[23]  Julien Michel,et al.  Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction , 2012, Journal of the American Chemical Society.

[24]  I. Dikic,et al.  Expanding the ubiquitin code through post‐translational modification , 2015, EMBO reports.

[25]  W. L. Jorgensen,et al.  Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α. , 2012, Angewandte Chemie.

[26]  H. Willems,et al.  Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery. , 2016, Journal of medicinal chemistry.

[27]  M. Ivan,et al.  Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.

[28]  T. Baker,et al.  Molecular basis of substrate selection by the N-end rule adaptor protein ClpS , 2009, Proceedings of the National Academy of Sciences.

[29]  T. Pawson,et al.  SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. , 1993, Science.

[30]  Michele Pagano,et al.  Mechanisms and function of substrate recruitment by F-box proteins , 2013, Nature Reviews Molecular Cell Biology.

[31]  Michael Knop,et al.  Efficient protein depletion by genetically controlled deprotection of a dormant N-degron , 2009, Molecular systems biology.

[32]  C. Crews,et al.  Small-Molecule PROTACS: New Approaches to Protein Degradation. , 2016, Angewandte Chemie.

[33]  A. Ciulli,et al.  Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4 , 2015, ACS chemical biology.

[34]  Toshihiko Ogura,et al.  Identification of a Primary Target of Thalidomide Teratogenicity , 2010, Science.

[35]  Tommer Ravid,et al.  Diversity of degradation signals in the ubiquitin–proteasome system , 2008, Nature Reviews Molecular Cell Biology.

[36]  M. Yaffe,et al.  Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response , 2013, Nature Reviews Molecular Cell Biology.

[37]  P. Jänne,et al.  Pharmacological Targeting of the Pseudokinase Her3 , 2014, Nature chemical biology.

[38]  Pedro Soares,et al.  Structure-Guided Design and Optimization of Small Molecules Targeting the Protein–Protein Interaction between the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities , 2014, Journal of medicinal chemistry.

[39]  Andreas Thomann,et al.  Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1α protein-protein interface. , 2012, Chemistry & biology.

[40]  G. Petzold,et al.  Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase , 2016, Nature.

[41]  C. Schofield,et al.  Evidence for a stereoelectronic effect in human oxygen sensing. , 2009, Angewandte Chemie.

[42]  T. Corson,et al.  Small-Molecule Hydrophobic Tagging Induced Degradation of HaloTag Fusion Proteins , 2011, Nature Chemical Biology.

[43]  Eunhwa Ko,et al.  Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL. , 2016, Angewandte Chemie.

[44]  M. Eck,et al.  SPLINTS: small-molecule protein ligand interface stabilizers. , 2016, Current opinion in structural biology.

[45]  M. Hannink,et al.  Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling , 2006, The EMBO journal.

[46]  J. Rizo,et al.  Jasmonate perception by inositol phosphate-potentiated COI1-JAZ co-receptor , 2010, Nature.

[47]  D. Barford,et al.  Insights into the anaphase-promoting complex: a molecular machine that regulates mitosis. , 2014, Current opinion in structural biology.

[48]  J. Caramelo,et al.  A sweet code for glycoprotein folding , 2015, FEBS letters.

[49]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[50]  J. Pruneda,et al.  Allosteric Activation of the RNF146 Ubiquitin Ligase by a Poly(ADP-ribosyl)ation Signal , 2014, Nature.

[51]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[52]  L. Hedstrom,et al.  Boc3Arg-Linked Ligands Induce Degradation by Localizing Target Proteins to the 20S Proteasome. , 2016, ACS chemical biology.

[53]  K. Nasmyth,et al.  Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability , 2001, Nature.

[54]  L. Hedstrom,et al.  Inhibitor mediated protein degradation. , 2012, Chemistry & biology.

[55]  Binh Vu,et al.  Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development. , 2013, ACS medicinal chemistry letters.

[56]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[57]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[58]  I. E. Smith,et al.  Catalytic in vivo protein knockdown by small-molecule PROTACs. , 2015, Nature chemical biology.

[59]  K. Zeth,et al.  Structural basis of N‐end rule substrate recognition in Escherichia coli by the ClpAP adaptor protein ClpS , 2009, EMBO reports.

[60]  Chin-Chun Lu,et al.  A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase , 2016, Nature.

[61]  D. Finley,et al.  Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.

[62]  Stefan Knapp,et al.  Crystal structure of the SOCS2–elongin C–elongin B complex defines a prototypical SOCS box ubiquitin ligase , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. D. de Oliveira,et al.  A combinatorial TIR1/AFB-Aux/IAA co-receptor system for differential sensing of auxin , 2012, Nature chemical biology.

[64]  C. Crews,et al.  Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. , 2015, Chemistry & biology.

[65]  T. Berg,et al.  Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a , 2015, Angewandte Chemie.

[66]  K. Vousden,et al.  Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl , 2012, Nature Structural &Molecular Biology.

[67]  James E. Bradner,et al.  Phthalimide conjugation as a strategy for in vivo target protein degradation , 2015, Science.

[68]  Min Jae Lee,et al.  A Neurostimulant para-Chloroamphetamine Inhibits the Arginylation Branch of the N-end Rule Pathway , 2014, Scientific Reports.

[69]  R. Deshaies.  Protein degradation: Prime time for PROTACs. , 2015, Nature chemical biology.

[70]  Anne Rascle,et al.  In vivo identification of novel STAT5 target genes , 2008, Nucleic acids research.

[71]  Geng Wu,et al.  Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. , 2003, Molecular cell.

[72]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[73]  Yoshiharu Kawaguchi,et al.  MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.

[74]  S. Carr,et al.  Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS , 2015, Nature.

[75]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[76]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[77]  Tatsuo Fukagawa,et al.  An auxin-based degron system for the rapid depletion of proteins in nonplant cells , 2009, Nature Methods.

[78]  Yigong Shi,et al.  Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies. , 2014, Journal of medicinal chemistry.

[79]  P. Grandi,et al.  Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition , 2016, Nature Communications.

[80]  D. Komander.  The emerging complexity of protein ubiquitination. , 2009, Biochemical Society transactions.